Session

Surgery or radiotherapy for localised and locally advanced prostate cancer

ESU Course 28

  • Location:
    Room 12 (ICM, Level 1)
  • Chair:
     B. Djavan, Vienna (AT)
  • Aims and objectives of this session

    The decision process towards surgery/active surveillance or radiation is a constantly evolving matter that requires a multitude of various information and inputs. In localised disease old habits have been jeopardised and surgical management seems to be fused with active surveillance in an increasing number of patients with good prognosticators. This course will summarise the decision process and indications for patients with clinically localised disease and help select the optimal treatment based on most recent oncological and functional data.
    In locally advanced disease, growing evidence supports the notion of radical surgery to improve outcome. US and European data endorse this policy in a selected group of patients. New radiation protocols and strategies combined with hormone therapy offer as much adequate alternatives. In the second part of this course, controversies regarding the optimal management of locally advanced prostate cancer patients will be discussed and clear recommendations made to facilitate patient counselling and treatment.

Localised prostate cancer
Introduction
 B. Djavan, Vienna (AT)
Treatment options and strategies in localised prostate cancer
 B. Djavan, Vienna (AT)
How and when to use nomograms and networks
 R.J.A. Van Moorselaar, Amsterdam (NL)
Oncology results of radiation therapy
 G. De Meerleer, Ghent (BE)
Oncological and functional results of radical prostatectomy
 B. Djavan, Vienna (AT)
Advanced prostate cancer
Radiotherapy with or without hormonal treatment in advanced PCA
 G. De Meerleer, Ghent (BE)
Adjuvant therapies following radical prostatectomy: What is the standard and what is new?
 R.J.A. Van Moorselaar, Amsterdam (NL)
Results of radical prostatectomy for T3 disease
 B. Djavan, Vienna (AT)
Take home messages
 B. Djavan, Vienna (AT)